Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur, Hopital Saint Louis, France

Prof. Dr. Carmen Lefaucheur is a highly accomplished nephrologist and expert in kidney transplantation. She serves as the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital, Paris, and is a Professor of Nephrology at Université Paris Cité. Additionally, she is the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR) and has an extensive background in personalized medicine for chronic diseases and organ transplantation. She holds multiple prestigious positions in international scientific committees and has received numerous awards, including the Paul I. Terasaki Clinical Science Award.

 

Publication profile

Orcid


Research Leadership
:

Dr. Lefaucheur is the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital and the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR). Her leadership in these roles highlights her impact in advancing research and clinical practice in nephrology and transplantation.

Research Excellence:

She has received numerous prestigious awards, including the Paul I. Terasaki Clinical Science Award and the European Society of Organ Transplantation Award, recognizing her contributions to the field. Her research publications are highly cited, with significant papers in top-tier journals such as Nature Medicine.

Grant Leadership:

Dr. Lefaucheur coordinates major research grants, including the RO1 Grant for biomarkers and digital pathology, indicating her pivotal role in funding and leading cutting-edge research.

International Influence:

Her extensive involvement with international committees and scientific societies, such as the European Society of Organ Transplantation (ESOT) and the American Society of Transplantation (AST), demonstrates her influence and recognition in the global research community.

Educational Contributions:

Her roles in organizing scientific meetings and her invitations to speak at major international congresses further underline her leadership and expertise.

Publication Top Notes

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation

Conclusion

Dr. Lefaucheur embodies the qualities of excellence in research and would be a strong candidate for this award.

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

  • Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
  • Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
  • High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
  • Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
  • Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
  • Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
  • Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
  • A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
  • Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
  • Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
  • A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
  • Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
  • A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥


Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus